Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Resected Stage IIB or IIC Melanoma in the United States

被引：0
|
作者：
Shujing Zhang
Arielle G. Bensimon
Ruifeng Xu
Ruixuan Jiang
Alexandra Greatsinger
Adina Zhang
Mizuho Fukunaga-Kalabis
Clemens Krepler
机构：
[1] Merck & Co.,
[2] Inc.,undefined
[3] Analysis Group,undefined
[4] Inc.,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Adjuvant treatment; Cost-effectiveness analysis; Pembrolizumab; Stage IIB–IIC melanoma; US health sector perspective;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3038 / 3055
页数：17
相关论文
共 50 条
  • [41] Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
    Dempsey, Timothy M.
    Thao, Viengneesee
    Moriarty, James P.
    Borah, Bijan J.
    Limper, Andrew H.
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [42] Cost-effectiveness analysis of pembrolizumab for treatment of US patients with persistent, recurrent, or metastatic cervical cancer
    Shi, Yang
    Chen, Jigang
    Shi, Bo
    Liu, Aihua
    GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 379 - 385
  • [43] Cost-effectiveness analysis of pembrolizumab in patients with treatment-refractory metastatic colorectal cancer in Japan
    Sugiura, Kiyoaki
    Hiratsuka, Hiroki
    Oshima, Go
    Aiko, Satoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (08) : 691 - 697
  • [44] Cost-effectiveness of Pembrolizumab in Combination with Chemotherapy as Neoadjuvant Treatment and Continued as a Single Agent Adjuvant Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer in Hong Kong
    Kwong, Ava
    Leung, Roland
    Chan, Tsz Ching
    Khandelwal, Anvi
    Mishra, Kshama
    Huang, Min
    ONCOLOGY AND THERAPY, 2024, 12 (03) : 525 - 547
  • [45] Retrospective cost-effectiveness analyses for polio vaccination in the United States
    Thompson, Kimberly M.
    Tebbens, Radboud J. Duintjer
    RISK ANALYSIS, 2006, 26 (06) : 1423 - 1440
  • [46] Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA Melanoma
    Ma, Emily Z.
    Terhune, Julia H.
    Zafari, Zafar
    Blackburn, Kyle W.
    Olson, John A., Jr.
    Mullins, C. Daniel
    Hu, Yinin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (04) : 521 - 528
  • [47] The cost-effectiveness of a modestly effective HIV vaccine in the United States
    Long, Elisa F.
    Owens, Douglas K.
    VACCINE, 2011, 29 (36) : 6113 - 6124
  • [48] Cost-effectiveness analysis of endovascular vs surgical arteriovenous fistula creation in the United States
    Mulaney-Topkar, Bianca
    Ho, Vy T.
    Sgroi, Michael D.
    Garcia-Toca, Manuel
    George, Elizabeth L.
    JOURNAL OF VASCULAR SURGERY, 2024, 79 (02)
  • [49] Cost-Effectiveness Analysis of Treatment Strategies for Stage I and II Endometrial Cancer
    Kwon, Janice S.
    Carey, Mark S.
    Goldie, Sue J.
    Kim, Jane J.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2007, 29 (02) : 131 - 139
  • [50] A cost-effectiveness analysis of universal hepatitis C screening in all United States pregnancies
    Susich, Marguerite
    Hersh, Alyssa R.
    Greiner, Karen
    Chaiken, Sarina R.
    Caughey, Aaron B.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25) : 7381 - 7388
12345